FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a method of treating muscular dystonias in a human being consisting in administering to the patient the therapeutically effective amounts of peptide DNWWPKPPHQGPRPPRPRPKP.
EFFECT: invention provides a local therapy of muscular dystonia with no side effects.
4 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING SPASTICITY ACCOMPANIED BY IMPROVED CONSCIOUSNESS IN PATIENTS IN VEGETATIVE STATE | 2012 |
|
RU2502503C1 |
| PEPTIDES AND THEIR DERIVATIVES WHICH INTERACT WITH NICOTINIC ACETYLCHOLINE RECEPTOR AND SUITABLE FOR USE IN COSMETOLOGY AGAINST MIMIC AND AGE-RELATED WRINKLES | 2013 |
|
RU2524428C1 |
| BOTULOTOXIN DOSAGE REGIMEN FOR PREVENTION OF CHRONIC MIGRAINE | 2011 |
|
RU2549981C9 |
| HIGH INTRODUCTION RATE OF NEUROTOXIC COMPONENT OF BOTULINUM TOXIN | 2007 |
|
RU2453333C2 |
| METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION BY MODIFIED CLOSTRIDIAL TOXIN | 2010 |
|
RU2568844C2 |
| COMPLEX, AGENT AND APPLICATION OF TYPE A BOTULINUM TOXIN CLOSTRIDIUM BOTULINUM | 2020 |
|
RU2783511C1 |
| METHOD FOR TREATMENT OF HEART DISEASES COMPLICATED WITH OSTEOCHONDROSIS AND OF PERIPHERAL VESSELS OF EXTREMITIES | 2004 |
|
RU2290229C2 |
| COMPOSITIONS AND METHODS FOR IMPROVING DRUG THERAPY WITH METAL ION DEPENDANT AGENTS | 2010 |
|
RU2540520C2 |
| METHOD OF TREATING MUSCULAR TONIC DISORDERS OF CHEWING MUSCULATURE | 2019 |
|
RU2731694C1 |
| CLOSTRIDIAL NEUROTOXINS WITH MODIFIED PERSISTENCE | 2009 |
|
RU2524429C2 |
